<DOC>
	<DOCNO>NCT00102531</DOCNO>
	<brief_summary>Phase Ib/IIa study determine safety efficacy inhale SLIT Cisplatin administer every week patient Osteosarcoma disease spread lung .</brief_summary>
	<brief_title>Inhalation SLIT Cisplatin Treatment Osteosarcoma Metastatic Lung</brief_title>
	<detailed_description>Osteosarcoma , preferentially metastasize lung . The presence lung metastases major impact prognosis patient osteosarcoma . Upon surgical removal tumor lung , new pulmonary metastasis often recur within month suggest micro-metastatic disease resistant systemic chemotherapy . The Sustained release lipid inhalation target ( SLIT ) technology offer potential ability attain prolonged therapeutic effect cisplatin lung sustain release . The ability give SLIT Cisplatin inhalation directly lung permit high drug level site disease low systemic exposure . Patients receive SLIT Cisplatin inhalation 14-day treatment cycle phase Ib/IIa , two-center , open-label , study design characterize maximum tolerate dose . Clinical efficacy endpoint include compare historical control , addition pharmacokinetics characterization . Efficacy evaluate least 2 cycle therapy . Safety data , include laboratory parameter adverse event collect determine qualitative quantitative toxicity , reversibility toxicity , SLIT Cisplatin . Pulmonary function test perform baseline , prior course off-study .</detailed_description>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologically proven , Progressive recurrent high grade osteosarcoma metastatic lung Measureable pulmonary metastasis . Less grade 3 neuropathy , insignificant decrease cardiac auditory function ECOG performance status 0 , 1 2 FEV1 50 % great predict value FEV1/FVC ratio 65 % great Serum creatinine &lt; /= 1.5 mg/dl Total bilirubin &lt; /= 1.5mg/dl SGOT SGPT &lt; 2.5 x upper normal limit ANC &gt; /= 1,000/mm3 platelet count &gt; = 100,000/mm3 Grade 3 high neuropathy Concurrent systemic chemotherapy Pulmonary atelectasis Significant reactive airway disease Concurrent serious infection Unstable serious concurrent medical condition Recent major surgery Significant pulmonary fibrosis Major ventilatory distribution abnormality Osteosarcoma secondary radiation premalignant condition History prior malignancy Low grade osteosarcoma , parosteal periosteal sarcoma</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Osteosarcoma</keyword>
	<keyword>relapse</keyword>
	<keyword>progressive</keyword>
	<keyword>metastatic</keyword>
	<keyword>lung</keyword>
</DOC>